The joint healthcare venture between Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan Chase said this week it named Brigham and Women’s Hospital surgeon, New Yorker magazine staff writer and bestselling author Dr. Atul Gawande as its CEO, effective July 9. The joint venture said that the newly formed company will be headquartered in Boston, and will operate […]
The joint healthcare venture between Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan Chase that looks to lower costs and improve health insurance is struggling to find the right individual to fill the corner office, according to a CNBC report. The joint venture began searching for a CEO after announcing its launch in January, according to the […]
Medtronic (NYSE:MDT) said today it tapped former J.P. Morgan Chase & Co. analyst Mike Weinstein as its strategy senior VP. Prior to joining Medtronic, Weinstein served as a managing director for JP Morgan’s equity research healthcare team, holding positions within the unit for more than 20 years, the Fridley, Minn.-based company said. “We are excited to […]
Shares in major health insurers UnitedHealth and Anthem fell today after online retail giant Amazon (NSDQ:AMZN), major holding company Berkshire Hathaway and JPMorgan Chase announced a collaborative, independent non-profit looking to provide their employees with healthcare. The three companies said they will look to “bring their scale and complimentary expertise” to the long-term project, which will […]
(Reuters) — Healthcare investors can expect a volatile week starting today, when the sector’s biggest financial event hits San Francisco. The annual JP Morgan healthcare conference, in which many healthcare companies present product and financial news to would-be investors, has been credited for helping the January outperformance of the healthcare sector in recent years. But after […]
Analyst: ConMed ripe for M&A spree May 19, 2015 by Fink Densford ConMed, in the middle of an under-appreciated turnaround, could be poised to augment its growth via selective acquisitions, according to Leerink Partners analyst Richard Newitter. Newitter, who upgraded CNMD shares to “outperform” and boosted the price target to $64 from $60, wrote in […]
The year ahead is looking to be an easier one for medical device companies navigating the European landscape, according to analysts with J.P. Morgan’s Europe Equity Research group.
Although austerity measures remain, major headwinds seem to be unwinding and patient volumes may finally be on the rebound as unemployment figures decline and consumer confidence grows.